Downtown Buffalo has a grand slam on its hands, with the opening of “The Original” Vasilis Restaurant. During a quick stop to pick up some delicious dolmades, I ran into owner Vasilis ...

LED Lighting Inc. Expands Leadership Team with the Appointment of Mary Karagiannis-Argyrides as Director of OEM and National Accounts Mary Karagiannis-Argyrides brings 30-plus years of lighting ...

Vasilis Gkatzelis is an associate professor of computer science in the College of Computing & Informatics at Drexel University. Gkatzelis' research interests include algorithmic mechanism design, ...

In a report released today, Andreas Argyrides from Oppenheimer maintained a Buy rating on Larimar Therapeutics (LRMR – Research Report), with a price target of $26.00. The company’s shares ...

He was assisted by six priests, including Frs. Christopher Argyrides and Charles Mihos, who served St. George for three quarters of a century. Fr. Mihos delivered the eulogy. Among the thousand ...

In a report released today, Andreas Argyrides from Oppenheimer maintained a Buy rating on United Therapeutics (UTHR – Research Report), with a price target of $600.00. The company’s shares ...

Lyons’ appointment comes six months after Stock pinched Goldies’ equities head, Mario Argyrides, who assumed the same role at Jefferies. Of note, Jefferies has also lured Firetrail Investments ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avadel Pharmaceuticals (AVDL – Research Report) and Rani Therapeutics Holdings (RANI – Research ...

Oppenheimer analyst Andreas Argyrides argued that nomlabofusp is designed to address the root cause of FA. Nomlabofusp delivers a protein called frataxin to the mitochondria of FA patients who ...

Martine Rothblatt; Founder, Chairperson, and Chief Executive Officer; United Therapeutics Corp James Edgemond; Chief Financial Officer and Treasurer; United Therapeutics Corp Michael Benkowitz ...

Oppenheimer analyst Andreas Argyrides sees great potential in Rani’s pipeline, noting that it could open the door to the global biologics market, which was valued at $516 billion in 2022 and is ...